Seven Tests Before the Ticker: A Buyer’s Checklist for London’s 2026 Listings

London’s equity capital markets enter the final weeks of 2026 with a familiar task: persuading issuers, advisers and investors that the pipeline can produce listings of genuine quality. A busier calendar would be welcome after several quiet years. It would not, by itself, prove that the market has regained its depth. The relevant question is not simply whether deals price. It is whether they leave behind liquid, well-governed companies with independent shareholders and functioning aftermarkets.

For investors assessing the 2026 IPO class, the following seven questions offer a sober checklist. None is decisive on its own. Together, they help separate a listing that broadens the opportunity set from one that mainly transfers risk from a seller to a buyer.

1. Is the free float large enough to trade?

Free float is the first test because it determines whether a public market actually exists after the closing bell. A company can list with a nominal free float and still trade like a private asset: wide spreads, thin volumes and violent moves on modest orders. Investors should ask what proportion of shares will be available to outside holders, how concentrated the remaining stake is and what daily turnover the advisers expect.

Liquidity is not a technicality. It affects the cost of entry and exit, the reliability of the share price and the willingness of larger funds to participate. A small float may suit a founder who wishes to retain control, but it weakens the public-market claim. For UK savers accessing new issues through funds or platforms, the practical question is whether they can build or reduce a position without moving the price against themselves.

2. Will the shares qualify for the main indices?

Index eligibility shapes demand. Inclusion in the FTSE UK Index Series can bring passive flows, benchmark-driven buying and greater visibility. It can also create a misleading impression of permanence. Investors should check free-float thresholds, liquidity tests, nationality and the likely timing of inclusion.

An index-driven bid is not the same as fundamental conviction. If a listing is designed primarily to capture passive money, the aftermarket may be fragile once that initial demand has been absorbed. A company that qualifies for inclusion is not automatically a good investment. A company that does not qualify is not automatically a bad one. The point is to understand the ownership base that the listing is likely to attract.

3. When do the lock-ups expire?

Lock-up arrangements are a map of future supply. Sponsors, founders and early investors usually agree not to sell for a period after listing. When those restrictions lapse, the market may face a significant increase in available shares. That does not mean insiders will sell, but it does mean the risk of an overhang should be priced and understood.

Investors should ask who is subject to lock-up, for how long and whether there are early-release provisions. A short lock-up with a large private-equity stake can create a visible supply event within months. A longer lock-up offers more stability, but it may also deter investors who want assurance that the register will broaden. The calendar matters as much as the headline free float.

4. Will there be research coverage beyond the syndicate?

IPO research has a conflicted history. The banks that bring a company to market have an incentive to support the story, and their coverage often begins with a favourable tone. The more important question is whether independent research will follow. A lack of analyst coverage can leave a newly listed company in an information vacuum, with fewer voices to challenge management and a wider spread between perception and reality.

For UK investors, coverage matters for governance as well as valuation. Companies that are followed by several independent analysts tend to face more scrutiny of forecasts, capital allocation and disclosure. A listing that relies solely on syndicate research may trade on narrative rather than evidence. That is a warning sign for anyone expecting the public market to impose discipline.

5. Where does the revenue actually come from?

A London listing is not a bet on the UK economy by default. Many companies choose London for access to investors, legal certainty or sector expertise while earning their revenue elsewhere. Investors should map the geography of sales, the currency of costs and the sensitivity of cash flows to UK policy.

This matters for both risk and valuation. A domestic consumer business faces different pressures from a company selling into North America or Asia. A sterling-denominated share price can obscure dollar or euro earnings. The question is not whether overseas revenue is good or bad. It is whether the investor understands the exposure being purchased and whether the valuation reflects it.

6. Is the governance structure fit for public ownership?

Governance is often reduced to board independence, but the IPO context demands a wider inquiry. Who controls the company after listing? Are there dual-class shares? How are related-party transactions handled? Is the audit committee genuinely independent? Do remuneration arrangements reward long-term capital allocation or short-term presentation?

A controlled company can be a perfectly respectable public company, provided minority shareholders understand the limits of their influence. The danger is a listing that presents the forms of public ownership without the substance. UK investors should read the prospectus for the bits that are easy to skip: shareholder agreements, conflict policies and the circumstances in which the controlling holder can act against the interests of the free float.

7. What will the proceeds actually do?

Use of proceeds is the simplest test and one of the most revealing. Is the company raising primary capital for growth, research, debt reduction or working capital? Or are the proceeds mainly buying out existing shareholders? Both can be legitimate, but they tell different stories. Primary capital strengthens the business. Secondary selling may simply provide an exit for private owners.

Investors should scrutinise the breakdown between primary and secondary shares, the assumed uses of funds and the company’s history of capital allocation. A listing that leaves the business better capitalised can deepen the market. A listing that mainly transfers ownership from one set of holders to another may still be useful for the seller, but it does less for UK capital formation.

The bellwether test

A genuine bellwether is not the deal that attracts the most headlines. It is the listing that creates a durable public company: enough free float to trade, a sensible index pathway, a manageable lock-up calendar, independent research, comprehensible revenue geography, credible governance and a clear use of proceeds. Those features deepen the market because they give investors reasons to participate beyond the first day of trading.

London does not need a rush of listings at any price. It needs a pipeline that can be judged on public-market terms. For investors, the seven tests are a way of resisting the atmosphere of an IPO. For the market itself, they are a reminder that a ticker is only the beginning.